Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07017998 · ClinicalTrials.gov registry record · NA
External Therapy for Tinnitus Management
A NA study of Tinnitus and Tinnitus, Subjective, sponsored by Restorear Devices.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07017998: Recruiting NA study of Tinnitus and Tinnitus, Subjective, sponsored by Restorear Devices.
NCT07017998 is a NA study of Tinnitus and Tinnitus, Subjective that is actively recruiting participants, run by Restorear Devices. The registered enrollment target is 80 participants, below the 12,616-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07017998, a NA study of Tinnitus and Tinnitus, Subjective, is actively recruiting participants, sponsored by Restorear Devices.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this remote interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for the symptomatic relief of chronic tinnitus. The main aims of the study are: 1. Ascertain the effects of MTH in chronic tinnitus patients using questionnaires measuring tinnitus severity and intervention-related change. 2. Ascertain the comfort and acceptability of the hypothermia device and therapy. Participants with chronic tinnitus will wear the mild therapeutic hypothermia therapy devices for a single 30 minute session. Researchers will compare results from those receiving therapy to those from a control group.
Primary Outcome
An adapted 4-question visual analog scale (VAS) will be used to assess tinnitus awareness, loudness, tolerance and disturbance before baseline treatment and repeated immediately after application using the online survey module. The VAS has been adapted to address the current, acute subjective experience of the participants' tinnitus rather than their general experience. The VAS consists of a sliding scale from 0 to 100, with 100 correlating to a greater disease burden/worse symptoms.
Conditions Studied
Interventions
- DEVICE Sham (No Treatment)
- DEVICE Cold pack-delivered mild therapeutic hypothermia
Study Locations (1)
Montana
- RestorEar Devices - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT07017998 shows while recruiting
NCT07017998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 12,616-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which Sham (No Treatment) is the first listed.
NCT07017998 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT07017998 about?
NCT07017998 is a clinical study titled "External Therapy for Tinnitus Management". The goal of this remote interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for the symptomatic relief of chronic tinnitus. The main aims of the study are: 1. Ascertain the effects of MTH in chronic tinnitus patients using questionnaires measuring tinnitu...
What is the current status of trial NCT07017998?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-07-16. Estimated completion is 2026-12-01.
What conditions does trial NCT07017998 study?
This clinical trial studies the following conditions: Tinnitus, Tinnitus, Subjective.
What interventions are being tested in trial NCT07017998?
The interventions under investigation include: Sham (No Treatment) (DEVICE), Cold pack-delivered mild therapeutic hypothermia (DEVICE).
Who is sponsoring clinical trial NCT07017998?
This trial is sponsored by Restorear Devices, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07017998 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07017998's enrollment target sits among peer trials
80 13th of 24 higher than 12 of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
-
Notched Noise Therapy for Suppression of Tinnitus
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI